US Tax Planning Mistakes Reducing Profits for Indian Pharma Companies - Indam Advisors
US tax planning mistakes can significantly reduce profits for Indian pharmaceutical companies operating in the USA. From incorrect entity structuring and transfer pricing errors to poor treaty utilization and missed tax credits, small compliance gaps can lead to heavy penalties. Strategic U.S. tax planning helps improve margins, ensure IRS compliance, and protect long-term profitability.